198 related articles for article (PubMed ID: 19745499)
1. Control of meningococcal meningitis outbreaks in sub-Saharan Africa.
Chippaux JP
J Infect Dev Ctries; 2008 Oct; 2(5):335-45. PubMed ID: 19745499
[TBL] [Abstract][Full Text] [Related]
2. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
Mueller JE; Borrow R; Gessner BD
Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617
[TBL] [Abstract][Full Text] [Related]
3. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.
Xie O; Pollard AJ; Mueller JE; Norheim G
Vaccine; 2013 Jun; 31(27):2852-61. PubMed ID: 23623866
[TBL] [Abstract][Full Text] [Related]
4. [Critical review of control strategies for meningococcal meningitis epidemics in Sub-Saharan Africa].
Chippaux JP; Debois H; Saliou P
Bull Soc Pathol Exot; 2002 Mar; 95(1):37-44. PubMed ID: 12012963
[TBL] [Abstract][Full Text] [Related]
5. Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps.
LaForce FM; Djingarey M; Viviani S; Preziosi MP
Hum Vaccin Immunother; 2018 May; 14(5):1098-1102. PubMed ID: 28968148
[TBL] [Abstract][Full Text] [Related]
6. [Meningococcal meningitis epidemics in sub-Saharan Africa and the meningococcal A conjugate vaccine].
Nicolas P
Med Sante Trop; 2012; 22(3):246-58. PubMed ID: 23186941
[TBL] [Abstract][Full Text] [Related]
7. Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa.
Mohammed I; Iliyasu G; Habib AG
Pathog Glob Health; 2017 Feb; 111(1):1-6. PubMed ID: 28081671
[TBL] [Abstract][Full Text] [Related]
8. Future Directions for Meningitis Surveillance and Vaccine Evaluation in the Meningitis Belt of Sub-Saharan Africa.
Novak RT; Ronveaux O; Bita AF; Aké HF; Lessa FC; Wang X; Bwaka AM; Fox LM
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S279-S285. PubMed ID: 31671452
[TBL] [Abstract][Full Text] [Related]
9. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.
Woods CW; Armstrong G; Sackey SO; Tetteh C; Bugri S; Perkins BA; Rosenstein NE
Lancet; 2000 Jan; 355(9197):30-3. PubMed ID: 10615888
[TBL] [Abstract][Full Text] [Related]
10. Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.
Micoli F; Romano MR; Tontini M; Cappelletti E; Gavini M; Proietti D; Rondini S; Swennen E; Santini L; Filippini S; Balocchi C; Adamo R; Pluschke G; Norheim G; Pollard A; Saul A; Rappuoli R; MacLennan CA; Berti F; Costantino P
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19077-82. PubMed ID: 24191022
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of fractional doses of tetravalent a/c/y/w135 meningococcal polysaccharide vaccine: results from a randomized non-inferiority controlled trial in Uganda.
Guerin PJ; Naess LM; Fogg C; Rosenqvist E; Pinoges L; Bajunirwe F; Nabasumba C; Borrow R; Frøholm LO; Ghabri S; Batwala V; Twesigye R; Aaberge IS; Røttingen JA; Piola P; Caugant DA
PLoS Negl Trop Dis; 2008; 2(12):e342. PubMed ID: 19048025
[TBL] [Abstract][Full Text] [Related]
12. Impact of serogroup A meningococcal conjugate vaccine for Africa.
Stuart JM
Hum Vaccin Immunother; 2018 May; 14(5):1116-1117. PubMed ID: 29194010
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of emerging vaccines for childhood meningococcal disease.
Choudhuri D; Huda T; Theodoratou E; Nair H; Zgaga L; Falconer R; Luksic I; Johnson HL; Zhang JS; El Arifeen S; Nelson CB; Borrow R; Campbell H; Rudan I
BMC Public Health; 2011 Apr; 11 Suppl 3(Suppl 3):S29. PubMed ID: 21501447
[TBL] [Abstract][Full Text] [Related]
14. Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017.
Fernandez K; Lingani C; Aderinola OM; Goumbi K; Bicaba B; Edea ZA; Glèlè C; Sarkodie B; Tamekloe A; Ngomba A; Djingarey M; Bwaka A; Perea W; Ronveaux O
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S225-S232. PubMed ID: 31671449
[TBL] [Abstract][Full Text] [Related]
15. Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis.
Munguambe AM; de Almeida AECC; Nhantumbo AA; Come CE; Zimba TF; Paulo Langa J; de Filippis I; Gudo ES
PLoS One; 2018; 13(8):e0197390. PubMed ID: 30089105
[TBL] [Abstract][Full Text] [Related]
16. Meningococcal disease control in countries of the African meningitis belt, 2014.
Wkly Epidemiol Rec; 2015 Mar; 90(13):123-31. PubMed ID: 25816448
[No Abstract] [Full Text] [Related]
17. Meningococcal conjugate vaccines.
Zimmer SM; Stephens DS
Expert Opin Pharmacother; 2004 Apr; 5(4):855-63. PubMed ID: 15102568
[TBL] [Abstract][Full Text] [Related]
18. Meningococcal vaccine in travelers.
Wilder-Smith A
Curr Opin Infect Dis; 2007 Oct; 20(5):454-60. PubMed ID: 17762777
[TBL] [Abstract][Full Text] [Related]
19. Conquering the meningococcus.
Stephens DS
FEMS Microbiol Rev; 2007 Jan; 31(1):3-14. PubMed ID: 17233633
[TBL] [Abstract][Full Text] [Related]
20. Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges.
Mustapha MM; Harrison LH
Hum Vaccin Immunother; 2018 May; 14(5):1107-1115. PubMed ID: 29211624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
